Dana Vuzman is an Instructor of Medicine at Harvard Medical School and the Director of Genomic Platform Development at DBMI. Vuzman oversees the implementation of the Clinical Genome Analysis Platform (CGAP) and the Single Cell RNA Platform in the Department. Prior to joining DBMI, she served as Chief Informatics Officer at One Brave Idea, Sr. Director of Biomedical Informatics at KEW, Inc. and co-Director at Brigham Genomic Medicine. Vuzman earned her PhD in Computational Biology from the Weizmann Institute of Science in Israel and completed her postdoctoral training in Computational Genetics at Brigham and Women’s Hospital and Harvard Medical School.